Self-selected women with polycystic ovary syndrome are reproductively and metabolically abnormal and undertreated

Fertil Steril. 2002 Jul;78(1):51-7. doi: 10.1016/s0015-0282(02)03153-9.

Abstract

Objective: To determine whether self-selected women with polycystic ovary syndrome (PCOS) are abnormal compared with a control population.

Design: Case-control.

Setting: Support group meeting organized and initiated by patients.

Patient(s): Forty-five self-selected women with PCOS and 80 control women.

Intervention(s): Self-selected women with PCOS at a peer support conference completed a questionnaire, had a brief physical, and gave a fasting blood sample.

Main outcome measure(s): Historical, biometric, and assay results.

Result(s): Sixty percent of the women attending the conference participated in the study. Most had been diagnosed with PCOS on the basis of ovarian morphology (35%). They were more likely to be nulliparous and have a history of oligomenorrhea (96%). They were hyperandrogenemic (significantly elevated testosterone and DHEAS levels) compared with control women. Self-selected women with PCOS displayed multiple metabolic abnormalities compared with control women, including elevations in blood pressure, waist-hip ratio, fasting insulin, fasting total cholesterol, and fasting low-density lipoprotein cholesterol levels, as well as a significant decrease in fasting glucose-insulin ratio and high-density lipoprotein cholesterol levels.

Conclusion(s): Self-selected women with PCOS have reproductive and metabolic abnormalities. The majority of these women received inadequate treatment despite having risk factors for endometrial cancer, diabetes, and/or heart disease. Our study also suggests that women attending or participating in a PCOS support group are willing and likely to participate in clinical studies.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Case-Control Studies
  • Female
  • Humans
  • Hyperandrogenism / epidemiology
  • Hyperandrogenism / etiology
  • Hyperandrogenism / therapy
  • Insulin Resistance*
  • Metabolic Diseases / epidemiology
  • Metabolic Diseases / etiology*
  • Metabolic Diseases / therapy
  • Oligomenorrhea / epidemiology
  • Oligomenorrhea / etiology*
  • Oligomenorrhea / therapy
  • Pennsylvania
  • Polycystic Ovary Syndrome / complications*
  • Polycystic Ovary Syndrome / physiopathology*
  • Polycystic Ovary Syndrome / therapy
  • Prevalence
  • Self-Help Groups*